MarketAnalysisMarketAnalysis
NYSE:ABT

Abbott Laboratories - NYSE:ABT - Comprehensive analysis

Free evaluation through quantitative algorithms Abbott Laboratories - NYSE:ABT

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

6.37

Market

52

Sector

63

Gross Profit Growth Over Prior Year

7.24

Market

62

Sector

55

EBITDA Growth Over Prior Year

8.74

Market

57

Sector

46

EBITA Growth Over Prior Year

-9.34

Market

14

Sector

25

EBIT Growth Over Prior Year

13.66

Market

76

Sector

29

Earnings from Cont. Ops. Growth Over Prior Year

143

Market

98

Sector

100

Net Income Growth Over Prior Year

143

Market

98

Sector

100

Normalized Net Income Growth Over Prior Year

15.14

Market

72

Sector

58

Diluted EPS before Extra Growth Over Prior Year

142

Market

98

Sector

100

A/R Growth Over Prior Year

0

Market

35

Sector

36

Inventory Growth Over Prior Year

0

Market

59

Sector

55

PPE Net Growth Over Prior Year

0

Market

42

Sector

55

Total Assets Growth Over Prior Year

0

Market

31

Sector

61

Tangible Book Value Growth Over Prior Year

476

Market

98

Sector

95

Common Equity Growth Over Prior Year

27.1

Market

88

Sector

96

Cash from Ops. Growth Over Prior Year

0

Market

52

Sector

32

CAPEX Growth Over Prior Year

0

Market

58

Sector

55

Dividend per Share Growth Over Prior Year

7.27

Market

64

Sector

100

Levered Free Cash Flow Growth Over Prior Year

0

Market

54

Sector

22

Unlevered Free Cash Flow Growth Over Prior Year

0

Market

56

Sector

32

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

57

Market

72

Sector

70

SG&A Margin %

26.2

Market

64

Sector

46

EBITDA Margin %

26.5

Market

67

Sector

77

EBITA Margin %

19.35

Market

67

Sector

77

EBIT Margin %

19.35

Market

65

Sector

81

Earnings from Cont. Ops Margin %

31.9

Market

94

Sector

100

Net Income Margin %

31.9

Market

94

Sector

100

Net Income Avail. for Common Margin %

31.8

Market

94

Sector

100

Normalized Net Income Margin %

11.76

Market

57

Sector

87

Levered Free Cash Flow Margin %

0

Market

26

Sector

46

Unlevered Free Cash Flow Margin %

0

Market

26

Sector

41

Return on Assets %

0

Market

7

Sector

73

Return on Capital %

8.88

Market

49

Sector

83

Return on Equity %

0

Market

8

Sector

70

Return on Common Equity %

30.8

Market

74

Sector

92

Total Asset Turnover

0

Market

15

Sector

17

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 33
Momentum: 57
Growth: 63
Profitability: 55

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

5.29

Market

66

Sector

60

TEV/LTM EBITDA

19.14

Market

78

Sector

66

P/LTM Normalized EPS

43.7

Market

78

Sector

69

P/BV

4.44

Market

60

Sector

70

TEV/LTM Unlevered FCF

36.3

Market

71

Sector

74

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

0.24

Market

68

Sector

66

3M Price Performance

-1.45

Market

53

Sector

47

6M Price Performance

-3.03

Market

40

Sector

43

9M Price Performance

-0.32

Market

51

Sector

57

1Y Price Performance

15.1

Market

72

Sector

69

Start analyzing Abbott Laboratories - NYSE:ABT with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports